AVNS Q1 2024 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$166M+4.3% YoY

Gross Profit

$95M57.1% margin

Operating Income

$7M4.5% margin

Net Income

-$900,000-0.5% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

-4.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$433M

Stockholders' Equity

$1.2B

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$166M	$159M	+4.3%
Gross Profit	$95M	$91M	+3.7%
Operating Income	$7M	$6M	+34.5%
Net Income	-$900,000	-$500,000	-80.0%

Revenue Segments

Digestive Health

$95M70%

Interventional pain

$40M30%